Publications

Faghihi-Kashani S, Yoshida A, Bozan F, et al. Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project. Arthritis Rheumatol. 2025;77(4):477-489.

Zanframundo G, Dourado E, Bauer-Ventura I, et al. The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project. Ann Rheum Dis. 2025;84(7):1207-1220.

Zheng B, Eline E, Xu L, Huang K, Hermans G, Perch M, Samoukovic G, De Langhe E, Dastmalchi M, Christopher-Stine L, Diederichsen LP, Leclair V. Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies-a potential lifesaving intervention. Rheumatology (Oxford). 2025;64(4):2204–2208.

Chen L, Fallavollita S, Sakr L, et al. Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1 γ (gamma) Antibody-Positive Dermatomyositis. Int J Rheum Dis. 2025;28(1):e70087.

Peterson JM, Leclair V, Oyebode OE et al. A window into intracellular events in myositis through subcellular proteomics. Inflamm. Res. 2025;74:31.

Nguyen N, Leclair V, Kaedbey R, Hudson M. Failure of daratumumab in the treatment of anti-synthetase syndrome: A case report. SAGE Open Medical Case Reports. 2025;13.

Cotton T, Hudson M, Troyanov Y, Leclair V, Gyger G. Nailfold capillaroscopy in myositis: A case series. SAGE Open Medical Case Reports. 2025;13.

Loganathan A, Zanframundo G, Yoshida A, et al. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank. Clin Exp Rheumatol. 2024;42(2):277-287.

Leclair V, Notarnicola A, Krystufkova O, Mann H, Andersson H, Diederichsen LP, Vencovsky J, Holmqvist M, Lundberg IE, Steele R, Hudson M. Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies. Semin Arthritis Rheum 2024.

Pijnenburg L, Giannini M, Bouchard-Marmen M, Arnaud L, Barsotti S, Bellando-Randone S, Bernardi L, Bini P, Blagojevic J, Codullo V, Couderc M, De Moreuil C, Dernis E, Diamanti L, Dubost JJ, Duval F, Emmi G, Galempoix JM, Geny B, Gottenberg JE, Groza M, Guffroy A, Guichard I, Guilpain P, Hervier B, Hudson M, et al. In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study. RMD Open 2023;9(3):e003081.

Amlani A, Choi MY, Buhler KA, Hudson M, Tarnopolsky M, Brady L, et al. Anti-Valosin-Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies. ACR Open Rheumatol. 2023;5(1):10-4.

Cordel N, Dechelotte B, Jouen F, Lamb JA , Chinoy H, New P, Vencovsky J, Mann H, Galindo-Feria AS, Dani L, Selva-O’Callaghan A, Werth VP, Ravishankar A, Landon-Cardinal O, et al. Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study. Rheumatology (Oxford) 2023;62(4):1711-1715.

Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M et al. Trial of Intravenous Immune Globulin in Dermatomyositis. N Engl J Med. 2022 Oct 6;387(14):1264-1278.

Meyer A, Troyanov Y, Kora P, Landon-Cardinal O, Leclair V, Bourré-Tessier J, Makhzoum JP, Isabelle C, Larue S, Grandmaison, Lepage M, Mansour AM, Satoh M, Fritzler MJ, Senécal JL, Hudson M, Karamchandani J, Ellezam B, O’Ferrall E. Myositis with prominent B-cell aggregates may mimic sporadic inclusion body myositis associated with a connective tissue disease: a case series. Neuromuscular Disorders 2022;33(2):169-182.

Ellezam B, Leclair V, Troyanov Y, Bersali I, Giannini M, Hoa S, Bourré-Tessier J, Nadon V, Drouin J, Karamchandani J, O’Ferrall E, Lannes B, Satoh M, Fritzler MJ, Senécal JL, Hudson M, Meyer A, Landon-Cardinal O. Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis. Neuropathol Appl Neurobiol. 2022;48(7):e12840.

Leclair V, D’Aoust J, Gyger G, Landon-Cardinal O, Meyer A, O’Ferrall E, Karamchandani J, Massie R, Ellezam B, Satoh M, Troyanov Y, Fritzler MJ, Hudson M. Autoantibody profiles delineate distinct subsets of scleromyositis. Rheumatology (Oxford). 2022;61(3):1148-57.

Ellezam B, Leclair V, Troyanov Y, Meyer A, Hudson M, Landon-Cardinal O. Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of ‘scleromyositis’. Acta Neuropathologica. 2021;142(2):395-397.

Cordel N, Dechelotte B, Jouen F, et al. Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study. Rheumatology (Oxford). Oct 17 2022.

Khoo T, Lilleker JB, Thong BYH. et al. Epidemiology of the idiopathic inflammatory myopathies. Nat Rev Rheumatol  2023;19:695–712.

Giannini M, Leclair V, Ellezam B, Troyanov Y, Hudson M, Senécal JL, Geny B, Landon-Cardinal O, Meyer Y. Scleromyositis: a Distinct Novel Entity within the Systemic Sclerosis and Autoimmune Myositis Spectrum. Implications for Care and Pathogenesis. Frontiers in Immunology 2023;13:974078.

Leclair V, Tsui H, Hudson M. Pain in autoimmune inflammatory myopathies – a scoping review. RMD Open 2023;9(1):e002591.

Lefebvre F, Giannini M, Ellezam B, Leclair V, Troyanov Y, Hoa S, Bourré-Tessier J, Satoh M, Fritzler MJ, Senécal JL, Hudson M, Meyer A, Landon-Cardinal O. Histopathological features of systemic sclerosis-associated myopathy: a scoping review. Autoimmunity 2021;20(7):102851.